MMV receives funding and support from government agencies, private foundations, international organizations, corporations, corporate foundations, and private individuals. These funds are used to finance the MMV portfolio of research and development projects to provide new, effective and affordable medicines for the treatment and prevention of malaria. They also support specific, targeted access and product management interventions to facilitate access to MMV products by vulnerable populations in malaria-endemic countries. See our past donors. Learn about our fundraising policy.
Australian Government - Department of Foreign Affairs and Aid
The Australian Government's overseas aid programme is improving the lives of millions of people in developing countries, delivering aid where it is most needed and most effective. Australian aid has helped its neighbours and countries further abroad to develop and focuses particularly on the Indo-Pacific region. Australia is internationally recognised for its leading role in the region, particularly in Papua New Guinea and the Pacific. Australia’s aid is even more important given two-thirds of the world’s poor—some 800 million people—live in the Asia Pacific.
Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.
The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials. MMV is part of the EDCTP2 programme supported by the European Union.
ExxonMobil Foundation is the primary philanthropic arm of ExxonMobil Corporation (NYSE:XOM) in the United States. The Foundation and the Corporation engage in a range of philanthropic activities that advance education, health and science in the communities where ExxonMobil has significant operations. Globally, ExxonMobil provides funding to improve basic education, promote women as catalysts for development, and combat malaria and other infectious diseases in developing countries.
Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is a non-profit organization aimed at promoting the discovery and development of new health technologies, including drugs, vaccines and diagnostics, for infectious diseases prevalent in developing countries. The first partnership of its kind in Japan, the GHIT Fund is a public-private partnership (PPP) established by the Government of Japan, a consortium of Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation.
Government of the Principality of Monaco
Monaco Government, through its public aid for development and international cooperation policy, has made the fight against poverty a priority for intervention. Each year, over 130 projects are supported by the Government in 12 countries (South Africa, Burkina Faso, Burundi, Lebanon, Madagascar, Mali, Morocco, Mauritania, Mongolia, Niger, Sénégal, Tunisia). Monegasque aid focuses on three areas of intervention: health, education for all and socio-economic integration, with a core focus on the most vulnerable populations (children, women, refugees, people with disabilities).
Irish Aid is the Irish Government’s official overseas development programme. Irish Aid works in partnership with governments and non-governmental organisations, in some of the world’s poorest countries in the ongoing and difficult fight against hunger, poverty and exclusion. The primary regional focus of the Irish Aid programme is with its nine programme countries, seven in Africa and two in Asia.
Netherlands Ministry of Foreign Affairs
Every year, the Netherlands contributes 0.8% of its GNP to poverty reduction. The Netherlands supports initiatives in 36 partner countries, including fragile states, to improve governance, focusing on human rights and a business climate conducive to jobs and good incomes. The same themes underpin Dutch efforts to improve education, water and sanitation, the environment and reproductive health and to fight HIV/AIDS. The Netherlands concentrates on these areas because they are essential to achieving the MDGs by 2015. To this end, the Netherlands is supporting partnerships with civil society organizations, businesses and educational institutions in rich and poor countries.
Newcrest Mining Limited
Newcrest Mining Limited is the largest gold producer listed on the ASX, and one of the top five gold mining companies globally by production, reserves and market capitalization. Newcrest’s portfolio is comprised predominantly of low cost, long life mines and a strong pipeline of brownfields and greenfields exploration projects. Newcrest has interests in six production provinces in four countries with a geographic focus in Australia, the Pacific region and Asia. Social responsibility, safety and sustainability are the fundamental guideposts to Newcrest’s vision to be The Miner of Choice.
The RIGHT Fund, established in July of 2018, is the first funding agency dedicated to supporting global health R&D through a three-way partnership between the Government of Korea (GOK), Korean life science companies, and international funders. The RIGHT Fund provides a platform for the GOK and Korean industry to increase their contributions to global health, and will serve as a vehicle for investment in R&D projects aimed at delivering tangible products to address disease burden in developing countries.
Swiss Agency for Development and Cooperation
The Swiss Agency for Development and Cooperation is Switzerland’s international cooperation agency within the Federal Department of Foreign Affairs (FDFA). In operating with other federal offices concerned, SDC is responsible for the overall coordination of development activities and cooperation with Eastern Europe, as well as for the humanitarian aid delivered by the Swiss Confederation. The Agency engages in direct operations, supports programmes of multilateral organizations, and helps to finance programmes run by Swiss and international relief organizations.
The Federal Ministry of Education and Research (BMBF) through KFW /(Germany)
The Federal Ministry of Education and Research (BMBF) promotes education, science and research. BMBF through KfW provides funding for product development partnerships (PDPs), which support selected international non-profit organizations in their cooperation with pharmaceutical companies and research institutes to develop medications, vaccines, and diagnostics for the fight against neglected diseases. MMV is sponsored by BMBF through KFW for the development of new medicines against malaria.
UK Department for International Development
DFID is the part of the UK government that manages Britain's aid to poor countries and works to get rid of extreme poverty. Its work is guided by two sets of targets: First, DFID is working to reach the Millennium Development Goals, the international targets agreed by the United Nations to halve world poverty by 2015. Second, the government’s Public Service Agreement (PSA) sets objectives and targets by which progress is measured towards this aim. DFID works with governments of developing countries as well as charities, businesses and international bodies, including the World Bank, UN agencies and the European Commission.
UNITAID uses innovative financing to fund projects for improved access to better treatments and diagnostics for HIV/AIDS, malaria and tuberculosis in low-income countries. UNITAID is the first global health organisation to use buy-side market leverage to make life-saving health products better and more affordable for developing countries and all in global health. Based in Geneva and hosted by the World Health Organization, approximately half of UNITAID’s finances come from a levy on air tickets.
USAID is the principal U.S. agency to extend assistance to countries recovering from disaster, trying to escape poverty, and engaging in democratic reforms. USAID's work supports long-term and equitable economic growth and advances U.S. foreign policy objectives by supporting: economic growth, agriculture and trade; global health; and, democracy, conflict prevention and humanitarian assistance.
World Health Organization
WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends. The WHO Global Malaria Programme is responsible for malaria surveillance, monitoring and evaluation, policy and strategy formulation, technical assistance, and coordination of WHO's global efforts to fight malaria.